Sugi Predict

Sugi Predict / Compounds / SCHEMBL7637428

SCHEMBL7637428

SCHEMBL7637428

CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CCCCC1

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1H O95180 9/20 0.93
▸ MAPT P10636 5/20 0.93
▸ MEN1 O00255 4/20 0.93
▸ KMT2A Q03164 4/20 0.93
▸ CACNA1B Q00975 3/20 0.93
▸ ALDH1A1 P00352 2/20 0.93
▸ CYP3A4 P08684 7/20 0.81
▸ CACNA1C Q13936 7/20 0.81
▸ CYP2D6 P10635 5/20 0.81
▸ MAPK1 P28482 3/20 0.78
▸ KCNH2 Q12809 2/20 0.78
▸ ABCB11 O95342 2/20 0.78
▸ NPC1 O15118 2/20 0.78
▸ TP53 P04637 2/20 0.78
▸ CYP1A2 P05177 2/20 0.78
▸ ALOX15 P16050 2/20 0.78
▸ CYP2C19 P33261 2/20 0.78
▸ THPO P40225 2/20 0.78
▸ MTOR P42345 2/20 0.78
▸ RAB9A P51151 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7631791 0.99 CACNA1H (0.95) CACNA1HMAPTMEN1KMT2ACACNA1B
SCHEMBL7405915 0.98 CACNA1H (0.95) CACNA1HMAPTMEN1KMT2ACACNA1B
SCHEMBL7395227 0.97 CACNA1H (1.00) CACNA1HMAPTMEN1KMT2ACACNA1B
Hydrochloric Acid SCHEMBL7630578 0.96 CACNA1H (1.00) CACNA1HMAPTMEN1KMT2ACACNA1B
Hydrochloric Acid SCHEMBL30179058 0.96 CACNA1H (1.00) CACNA1HMAPTMEN1KMT2ACACNA1B
Hydrochloric Acid SCHEMBL30540990 0.95 CACNA1H (0.99) CACNA1HMAPTMEN1KMT2ACACNA1B
SCHEMBL7404917 0.90 CACNA1H (0.82) CACNA1HMAPTMEN1KMT2ACACNA1B
SCHEMBL22734733 0.90 CYP3A4 (1.00) CACNA1HMAPTMEN1KMT2ACACNA1B
SCHEMBL22761563 0.90 CYP3A4 (1.00) CACNA1HMAPTMEN1KMT2ACACNA1B
SCHEMBL22761564 0.90 CYP3A4 (1.00) CACNA1HMAPTMEN1KMT2ACACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410743-B2 (1S,2S)-2-(2-(N-((3-BENZOIMIDAZOL-2-YL)PROPYL)-N-METHYLAMINO)ETHYL)-6 -FLUORO-1,2,3,4-TETRAHYDRO-1-ISOPROPYL-2-NAPHTHYL CYCLOPROPANECARBOXYLATE, FOR EXAMPLE; TREATING VASCULAR DISEASE SUCH AS GANGRENE, RETINOPATHY, NEPHROPATHY NOVO NORDISK A/S (DK) 2002-06-25 — — US claimed
US-20010041730-A1 Tetrahydronaphtalene derivatives and their use SOUTH ALABAMA MEDICAL SCIENCE FOUDATION 2001-11-15 — — US claimed
US-6410743-B2 (1S,2S)-2-(2-(N-((3-BENZOIMIDAZOL-2-YL)PROPYL)-N-METHYLAMINO)ETHYL)-6 -FLUORO-1,2,3,4-TETRAHYDRO-1-ISOPROPYL-2-NAPHTHYL CYCLOPROPANECARBOXYLATE, FOR EXAMPLE; TREATING VASCULAR DISEASE SUCH AS GANGRENE, RETINOPATHY, NEPHROPATHY NOVO NORDISK A/S (DK) 2002-06-25 — — US disclosed
US-20010041730-A1 Tetrahydronaphtalene derivatives and their use SOUTH ALABAMA MEDICAL SCIENCE FOUDATION 2001-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010041730-A1 Tetrahydronaphtalene derivatives and their use CACNA1G, CACNA1I, CACNA1H CACNA1H 3/4885MAPT 562/4885MEN1 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.